Dr. Rojas-Quintero is researching how Metformin, a long-used diabetes drug, may be able to slow fibrosis in the lungs.
TipRanks on MSN
GSK’s New COPD Study: A Potential Game-Changer?
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is launching a new clinical study titled A ...
PHILADELPHIA (WPVI) -- COPD is one of the nation's biggest health problems - up to 24 million Americans may suffer from it. Temple Health is involved in trials for an innovative treatment to cut COPD ...
Regeneron Pharmaceuticals ((REGN)), Sanofi SA ((SNY)), Sanofi ((SNYNF)), Sanofi ((DE:SNW)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock ...
The disappointing result means that AZ will be unable to follow in the footsteps of GSK, whose IL-5 inhibitor Nucala ...
An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...
It takes people with COPD longer to exhale all the air from their lungs, often because of narrowing and damage in the airways. COPD is an umbrella term that includes chronic obstr ...
CHICAGO, July 8, 2025 /PRNewswire/ -- The American Lung Association is launching a new campaign to support and empower individuals living with chronic obstructive pulmonary disease (COPD) in rural and ...
Veterans with COPD and current tobacco use faced a reduced likelihood for tobacco dependence treatment if they lived in a ...
Using a care pathway focused on chronic obstructive pulmonary disease (COPD) can lead to shorter hospital stays, increased referrals to pulmonary rehabilitation, and improved standardization of care, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results